Gut enzyme discovery sheds light on bilirubin balance in humans

FHS
January 7, 2024
11:39 pm

Researchers study identified BilR, a gut microbiota-derived enzyme, crucial for converting bilirubin to urobilinogen, impacting bilirubin homeostasis in humans.

Why Cybin Could See Greater Opportunities After MAPS 2023

[embedded content] We’ve been enjoying our time on location at the MAPS Psychedelics Science Conference, and in our latest Trade to Black we are back

June 26, 2023

Bristol Myers pays $350M upfront for rights to heart drug Camzyos in Asia

Bristol Myers Squibb is setting up a deal with Shanghai-based LianBio to get the rights to the heart drug Camzyos in China and several other

October 25, 2023

How Does Heat Kill? It Confuses the Brain, Shuts Down Organs, and Strains the Heart.

As temperatures and humidity soar outside, what’s happening inside the human body can become a life-or-death battle decided by just a few degrees. The critical

June 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.